Performance of deamidated gliadin peptide antibodies as first screening for celiac disease in the general pediatric population
BackgroundCeliac serology has evolved, with the identification of newer antibodies against deamidated gliadin peptides (DGP) [e.g., anti-DGP, immunoglobulin A (IgA), and immunoglobulin G (IgG) types] with sensitivity and specificity in detecting celiac disease (CeD) that are equivalent to anti-tissu...
Main Authors: | Abdulrahman Al-Hussaini, Abdullah Al-Jurayyan, Sahar Alharbi, Muhammed Salman Bashir, Riccardo Troncone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2023.1279825/full |
Similar Items
-
Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease
by: Ádám Diós, et al.
Published: (2022-02-01) -
Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease
by: E A Sabel'nikova, et al.
Published: (2014-02-01) -
Diagnostic Accuracy of IgA Anti-Transglutaminase and IgG Anti-Deamidated Gliadin for Diagnosis of Celiac Disease in Children under Two Years of Age: A Systematic Review and Meta-Analysis
by: Giulia N. Catassi, et al.
Published: (2021-12-01) -
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!
by: Michele Arigliani, et al.
Published: (2017-08-01) -
Development of celiac-safe foods: prevention of transglutaminase 2 (TG2) deamidation of gluten in healthy non-celiac volunteers
by: Niklas Engström, et al.
Published: (2024-03-01)